Related Experiment Video
Updated: Sep 26, 2025

05:57
3D Analysis of Multi-cellular Responses to Chemoattractant Gradients
Published on: May 24, 2019
6.7K
3D Printed Cell Culture Chamber for Testing the Effect of Pump-Based Chronic Drug Delivery on Inner Ear Tissue
Jana Schwieger1,2,3, Anna Sophie Frisch1,2, Thomas S Rau1,2,3
1Department of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, 30625 Hannover, Germany.
Biomolecules
|April 23, 2022
Summary
A novel inner ear chamber enables long-term drug delivery to study spiral ganglion neurons (SGNs) for hearing loss. Neurotrophin-3 significantly boosted SGN neurite outgrowth, suggesting potential for improved cochlear implant function.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Otolaryngology
Background:
- Sensory neural hearing loss results from cochlear hair cell damage and spiral ganglion neuron (SGN) degeneration.
- Cochlear implants (CIs) electrically stimulate SGNs, but their functionality depends on SGN health and proximity to electrodes.
- Neurotrophic factors may improve SGN survival and neurite outgrowth, optimizing the electrode-nerve interaction for better CI performance.
Purpose of the Study:
- To develop and validate an in vitro model for chronic drug delivery to SGNs.
- To investigate the potential of neurotrophic factors to enhance SGN neurite outgrowth for improved CI functionality.
Main Methods:
- Designed and 3D-printed a novel, inner ear-inspired Neurite Outgrowth Chamber (NOC).
- Incorporated a mini-osmotic pump for controlled, long-term drug delivery within the NOC.
- Validated the NOC using spiral ganglion explants treated with ciliary neurotrophic factor, neurotrophin-3, or control fluid over two weeks.
Main Results:
- The NOC successfully supported explant cultivation and observed pump-based drug delivery over 14 days.
- Neurotrophin-3 treatment significantly increased SGN neurite outgrowth compared to control and ciliary neurotrophic factor groups.
- The model demonstrated suitability for assessing the effects of chronic neurotrophic factor delivery on SGNs.
Conclusions:
- The developed Neurite Outgrowth Chamber is a viable in vitro model for studying chronic drug delivery to spiral ganglion neurons.
- Neurotrophin-3 shows promise in promoting SGN neurite outgrowth, potentially enhancing cochlear implant efficacy.
- This model could facilitate further research into neuroprotective strategies for sensory neural hearing loss.

